Transport mechanical ventilation during cardiopulmonary resuscitation in out-of-hospital cardiac arrest: an exploratory prehospital pilot study
摘要
Evidence regarding the use of mechanical ventilation (MV) during cardiopulmonary resuscitation (CPR) in out-of-hospital cardiac arrest (OHCA) remains limited, particularly in prehospital settings.
ObjectiveTo evaluate the feasibility and generate preliminary physiologic data regarding transport MV compared with bag-valve ventilation (BV) during CPR in OHCA.
MethodsThis prospective, time-sequenced, exploratory pilot study, conducted between September 2024 and October 2025, included adult OHCA patients aged ≥ 18 years managed by the Ramathibodi Emergency Medical Operation team. Patients received BV during the first 6 months, followed by MV thereafter, delivered using a HAMILTON-T1 transport mechanical ventilator in volume-controlled mode (tidal volume: 6–8 mL/kg; respiratory rate: 10 breaths/min; PEEP: 0 cmH₂O; I:E ratio: 1:5; FiO₂: 1.0; flow trigger: off). Ventilation was assessed using arterial or venous PCO₂ obtained after ≥ 3 min following intubation or upon return of spontaneous circulation (ROSC). As a pilot study, this investigation was not powered to detect differences in clinical outcomes.
ResultsForty-one patients were analysed (29 BV, 12 MV). The mean age was 67 ± 15 years in the BV group and 66 ± 20 years in the MV group, with 55.2% and 66.7% male patients, respectively. No statistically significant differences were detected in PCO₂, pH, or pO₂ between groups. Clinical outcomes, including sustained ROSC and 28-day survival, were also similar between groups. Mechanical ventilation was operationally feasible in the prehospital setting despite several implementation challenges.
ConclusionIn this exploratory prehospital pilot study, MV during CPR was feasible and produced preliminary physiologic measures comparable to BV. These findings are hypothesis-generating and may inform the design of future adequately powered studies.
Trial registrationThe study protocol was registered with the Thai Clinical Trials Registry (TCTR20241008007; 08 October 2024).